USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: OPTOFLUIDICS, INC.
City: Philadelphia
State: PA
Zip+4: 19104-5533
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: http://opfluid.com
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $349,022.00 3
SBIR Phase II $1,874,829.00 2

Award List:

SBIR Phase I: Single Molecule NanoTweezers

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: NSF
Principal Investigator: David Erickson
Award Amount: $149,370.00
Abstract:
This Small Business Innovation Research Phase I project aims to develop a commercial optically resonant nanotweezer chip. The nanotweezer technology, originally developed at Cornell University, uses photonic resonance to localize optical forces so they can be used to directly manipulate biological… More

"Point of Injury"Sampling Technology for Battlefield Molecular Diagnostics

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: DOD
Principal Investigator: Bernardo Cordovez, Principle Scientist&CTO – (607) 272-2617
Award Amount: $99,811.00
Abstract:
In this project Optofluidics, Inc. proposes to develop a"CLIA waivable"sample collection method for the concentration and quantification of blood-borne biomarkers associated with late phase hemorrhagic shock and traumatic brain injury. The sample collection technology is based on (1) a… More

SBIR Phase II: Single Molecule NanoTweezers

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: NSF
Principal Investigator: Bernardo Cordovez
Award Amount: $499,591.00
Abstract:
This Small Business Innovation Research Phase II project aims to develop a commercial optically-resonant nanotweezer chip and corresponding instrumentation. The nanotweezer technology, originally developed at Cornell University, uses localized optical forces to directly manipulate biological… More

Point of Injury Sampling Technology for Battlefield Molecular Diagnostics

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency / Branch: DOD / DARPA
Principal Investigator: Robert Hart, Principal Scientist – (215) 966-6251
Award Amount: $1,375,238.00
Abstract:
In this project Optofluidics, Inc. proposes to develop the Molecular Medic a point-of-care device for sample collection, processing, and quantification of blood-borne biomarkers. The technology is based on (1) a finger prick assay, (2) a capillary-driven blood filtration system, (3) a… More

QuitAdvisorDDS: A Point-of-Care Tobacco Cessation Tool for Dental Settings

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: HHS
Principal Investigator: Robert W. Hart – 215-966-6252
Award Amount: $99,841.00
Abstract:
DESCRIPTION: Optofluidics Inc. proposes to develop a novel protein-binding assay platform called the BioPrism. The Bioprism is a multiplexable, label-free, bead-based binding assay. The system will be ideal for in vitro molecular diagnostics, therapeuticdevelopment and molecular biology research.… More